Fresenius Medical Care, North America, Waltham, MA 02451-1457, USA.
Am J Kidney Dis. 2011 Aug;58(2):235-42. doi: 10.1053/j.ajkd.2011.04.015. Epub 2011 Jun 12.
Patients' education about transplant, hemodialysis (HD), peritoneal dialysis (PD), and conservative care often is provided by nephrologists as needed and occurs as time allows.
Quality improvement report.
SETTING & PARTICIPANTS: Attendees of a national treatment options program (TOPs) who initiated long-term dialysis therapy (median, 3.4 months) at Fresenius Medical Care, North America facilities throughout 2008 were compared with period-prevalent incident patients receiving usual care.
Standardized predialysis treatment options education.
Rates of opting for PD modality, arteriovenous HD access at initiation, and early (90-day) mortality risk.
Logistic regression (for choice of PD and HD access type) and Cox models (for early mortality) were constructed, including a 1:1 matched cohort. A post hoc sensitivity analysis also compared a propensity score-matched cohort.
3,165 TOPs attendees (10.5% of 30,217 incident patients admitted between January 1 and December 31, 2008), were younger, more likely to be white, and had slightly larger body surface area. The unadjusted OR for TOPs attendees for selecting PD therapy was 8.45 (95% CI, 7.63-9.37) with a case-mix plus laboratory-adjusted OR of 5.13 (95% CI, 3.58-7.35). For patients who opted for in-center HD therapy, the OR was 2.14 (95% CI, 1.96-2.33) and adjusted OR was 2.06 (95% CI, 1.88-2.26) for starting with a fistula or graft. The unadjusted early mortality HR was 0.51 (95% CI, 0.43-0.60) and case-mix plus laboratory-adjusted adjusted HR was 0.61 (95% CI, 0.50-0.74) for TOPs attendees (all outcomes, P < 0.001). These results were consistent in the 1:1 matched analysis and propensity score-matched analysis.
It is possible that physicians who referred to these programs were more likely to prescribe PD therapy or place arteriovenous accesses. Motivated, treatment-adherent patients (who would have better outcomes) may have self-selected to attend education sessions.
Attending an options class predialysis was associated with more frequent selection of home dialysis, fewer tunneled HD catheters, and lower mortality risk during the first 90 days of dialysis therapy.
患者接受有关移植、血液透析 (HD)、腹膜透析 (PD) 和保守治疗的教育通常由肾病医生根据需要提供,并在有时间的情况下进行。
质量改进报告。
2008 年在 Fresenius Medical Care,北美各地设施开始长期透析治疗(中位数 3.4 个月)的全国治疗选择计划 (TOPs) 参与者与接受常规护理的同期发病患者进行了比较。
标准化透析前治疗选择教育。
选择 PD 治疗方式、起始时动静脉 HD 通路以及早期(90 天)死亡率的比例。
构建了逻辑回归(用于 PD 和 HD 通路类型的选择)和 Cox 模型(用于早期死亡率),包括 1:1 匹配队列。事后敏感性分析还比较了倾向评分匹配队列。
3165 名 TOPs 参与者(2008 年 1 月 1 日至 12 月 31 日期间入院的 30217 名新发病例患者的 10.5%)年龄较小,更可能是白人,并且体表面积略大。未经调整的 TOPs 参与者选择 PD 治疗的比值比为 8.45(95%CI,7.63-9.37),病例组合加实验室调整的比值比为 5.13(95%CI,3.58-7.35)。对于选择中心内 HD 治疗的患者,比值比为 2.14(95%CI,1.96-2.33),调整后的比值比为 2.06(95%CI,1.88-2.26),起始时使用瘘管或移植物。未经调整的早期死亡率 HR 为 0.51(95%CI,0.43-0.60),病例组合加实验室调整的调整 HR 为 0.61(95%CI,0.50-0.74)对于 TOPs 参与者(所有结果,P<0.001)。在 1:1 匹配分析和倾向评分匹配分析中,这些结果是一致的。
可能是转诊至这些项目的医生更有可能开出 PD 治疗或放置动静脉通路。积极治疗、依从性好的患者(会有更好的结果)可能会自行选择参加教育课程。
透析前参加选项课程与更频繁地选择家庭透析、较少使用隧道 HD 导管以及在透析治疗的前 90 天内降低死亡率风险相关。